251 - 260 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Symptomatic Care in Multiple System Atrophy: State of the ArtJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 3Start Page: 433End Page: 446Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-022-01411-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-022-01411-6.pdfCitation Count: 7
-
RESTRICTEDTitle: Digital Technology in Movement Disorders: Updates, Applications, and ChallengesJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-021-01101-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11910-021-01101-6.pdfCitation Count: 30
-
RESTRICTEDTitle: Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 34Issue #: 6Start Page: 559End Page: 577Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-020-00727-3Citation Count: 6
-
RESTRICTEDTitle: 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical RecommendationsJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 2Start Page: 137End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-020-00782-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-020-00782-w.pdfCitation Count: 17
-
RESTRICTEDTitle: Targeting β-Arrestins in the Treatment of Psychiatric and Neurological DisordersJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 3Start Page: 253End Page: 264Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-021-00796-yCitation Count: 8
-
RESTRICTEDTitle: Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysisJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1269End Page: 1283Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-022-00963-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-022-00963-9.pdfCitation Count: 14
-
RESTRICTEDTitle: Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1249End Page: 1267Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-022-00973-7Citation Count: 5
-
RESTRICTEDTitle: The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and SuitabilityJournal Name: Drugs & AgingPublisher: Springer Science and Business Media LLCVol: 38Issue #: 5Start Page: 355End Page: 373Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40266-021-00853-7Best OA location URL: https://discovery.ucl.ac.uk/10124963/5/Foltynie_Incretin-based_Therapies_Review_CG_24.02.21CA.pdfCitation Count: 6
-
RESTRICTEDTitle: Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's DiseaseJournal Name: DrugsPublisher: Springer Science and Business Media LLCVol: 82Issue #: 10Start Page: 1027End Page: 1053Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40265-022-01747-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40265-022-01747-7.pdfCitation Count: 9
-
RESTRICTEDTitle: Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluidJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 62Issue #:Start Page: 101130End Page: 101130Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2020.101130Citation Count: 26